NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.88+0.18 (+2.76%)
Close on Nov 18, 2026Market cap $31.52MP/E –Yield 0.00%
NextCure net income
Net income is the profit left for shareholders after every expense, interest and tax.
NextCure's net income for the twelve months ending Jun 30, 2026 was -$42.75M. For fiscal 2025 it was -$55.84M. The highest annual figure on record is -$22.80M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$55.84M | – |
| FY2024 | Dec 31, 2024 | -$55.65M | – |
| FY2023 | Dec 31, 2023 | -$62.72M | – |
| FY2022 | Dec 31, 2022 | -$74.73M | – |
| FY2021 | Dec 31, 2021 | -$69.39M | – |
| FY2020 | Dec 31, 2020 | -$36.60M | – |
| FY2019 | Dec 31, 2019 | -$33.74M | – |
| FY2018 | Dec 31, 2018 | -$22.80M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$14.89M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.80M | – |
| Q4 FY2025 | Dec 31, 2025 | -$9.44M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$26.81M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.60M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.54M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.40M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.11M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.47M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.30M | – |
| Q2 FY2023 | Jun 30, 2023 | -$17.86M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.10M | – |
| Q4 FY2022 | Dec 31, 2022 | -$17.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.91M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.92M | – |
| Q1 FY2022 | Mar 31, 2022 | -$20.60M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.94M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.93M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.99M | – |
| Q1 FY2021 | Mar 31, 2021 | -$16.53M | -269.9% |
| Q4 FY2020 | Dec 31, 2020 | -$15.46M | – |
| Q3 FY2020 | Sep 30, 2020 | -$16.37M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.51M | – |
| Q1 FY2020 | Mar 31, 2020 | $9.73M | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.93M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.43M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.22M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.16M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.86M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.71M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.23M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.00M | – |
See a number that looks wrong?